Enhanced invasive properties exhibited by smooth muscle cells are associated with elevated production of MMP-2 in patients with aortic aneurysms

被引:48
作者
Goodall, S [1 ]
Porter, KE [1 ]
Bell, PR [1 ]
Thompson, MM [1 ]
机构
[1] Univ Leicester, Leicester Royal Infirm, Dept Surg, Leicester LE2 7LX, Leics, England
关键词
smooth muscle cell; aneurysm; matrix metalloproteinase-2; migration; invasion;
D O I
10.1053/ejvs.2002.1675
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: abdominal aortic aneurysms (AAA) are associated with excessive vascular matrix remodelling. Recent findings suggest a systemic overproduction of matrix metalloproteinases-2 (MMP-2) by vascular smooth muscle cells (SMC) may be pivotal aetiologically. SMC migration is facilitated by MMP mediated proteolysis of. the basement membrane and extracellular matrix. Our aim was to see if enhanced MMP-2 production by these SMC exhibit increased invasion, in an in vitro model of migration. Method: SMC were derived from inferior mesenteric vein (IMV) harvested from patients aneurysm repair (n = 6) or colectomy for diverticulosis (n = 6, control). Using a modified Boyden chamber chemotaxis was measured towards platelet derived growth factor (PDGF) and foetal Calf Serum (FCS) and invasion through a Matrigel layer. MMP-2 production was quantified by ELISA and gelatin zymography. Results: chemoattractant studies demonstrated no difference in the effect of PDGF or FCS between the two populations of SMC. However, invasive studies demonstrated a significant increase in the number of migrating SMC isolated from IMV of AAA patients. Analysis of culture media extracts revealed that this difference was associated with a significant increase in production of MMP-2. Conclusion: SMC derived from patients with AAA demonstrate increased invasive properties When compared to 47 Control group. Increased migration appears to be due to overproduction of MMP-2. The enhanced migratory potential of these SMC may lead to extracellular matrix remodelling and subsequent medial disruption demonstrated in the aneurysmal aorta. These data further support evidence of the proteolytic role of MMP-2 in cell migration.
引用
收藏
页码:72 / 80
页数:9
相关论文
共 39 条
[1]
MATRIX METALLOPROTEINASE-2 IS AN INTERSTITIAL COLLAGENASE - INHIBITOR-FREE ENZYME CATALYZES THE CLEAVAGE OF COLLAGEN FIBRILS AND SOLUBLE NATIVE TYPE-I COLLAGEN GENERATING THE SPECIFIC 3/4-LENGTH AND 1/4-LENGTH FRAGMENTS [J].
AIMES, RT ;
QUIGLEY, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) :5872-5876
[2]
Cyclic GMP-dependent protein kinase expression in coronary arterial smooth muscle in response to balloon catheter injury [J].
Anderson, PG ;
Boerth, NJ ;
Liu, M ;
McNamara, DB ;
Cornwell, TL ;
Lincoln, TM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (10) :2192-2197
[3]
Focalized proteolysis: Spatial and temporal regulation of extracellular matrix degradation at the cell surface [J].
Basbaum, CB ;
Werb, Z .
CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (05) :731-738
[4]
ELASTIN CONTENT, CROSS-LINKS, AND MESSENGER-RNA IN NORMAL AND ANEURYSMAL HUMAN AORTA [J].
BAXTER, BT ;
MCGEE, GS ;
SHIVELY, VP ;
DRUMMOND, IAS ;
DIXIT, SN ;
YAMAUCHI, M ;
PEARCE, WH .
JOURNAL OF VASCULAR SURGERY, 1992, 16 (02) :192-200
[5]
Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury [J].
Bendeck, MP ;
Irvin, C ;
Reidy, MA .
CIRCULATION RESEARCH, 1996, 78 (01) :38-43
[6]
CONTROL OF GROWTH AND DIFFERENTIATION OF VASCULAR CELLS BY EXTRACELLULAR-MATRIX PROTEINS [J].
CAREY, DJ .
ANNUAL REVIEW OF PHYSIOLOGY, 1991, 53 :161-177
[7]
MIGRATION OF SMOOTH-MUSCLE AND ENDOTHELIAL-CELLS - CRITICAL EVENTS IN RESTENOSIS [J].
CASSCELLS, W .
CIRCULATION, 1992, 86 (03) :723-729
[8]
Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration [J].
Chapman, HA .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (05) :714-724
[9]
Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms [J].
Crowther, M ;
Goodall, S ;
Jones, JL ;
Bell, PRF ;
Thompson, MM .
JOURNAL OF VASCULAR SURGERY, 2000, 32 (03) :575-583
[10]
Deryugina EI, 1997, ANTICANCER RES, V17, P3201